Glucosylceramide Synthase Inhibitor [EPC] - N0000175783

Pharmacologic Class Information

Pharmacologic Code N0000175783
Pharmacologic Name Glucosylceramide Synthase Inhibitor
Pharmacologic Uses
  • glucosylceramide synthase inhibitor
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Glucosylceramide Synthase Inhibitor

The table contains 6 products whose active ingredient are classified under the same pharmacologic class Glucosylceramide Synthase Inhibitor [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
10148-201Miglustat Non-Proprietary Name: MiglustatCapsuleOralCotherix, Inc.ACTIVE
42799-709Yargesa Non-Proprietary Name: MiglustatCapsuleOralEdenbridge Pharmaceuticals Llc.ACTIVE
43975-310Miglustat Non-Proprietary Name: MiglustatCapsuleOralAni Pharmaceuticals, Inc.ACTIVE
58468-0220Cerdelga Non-Proprietary Name: EliglustatCapsuleOralGenzyme CorporationACTIVE
66215-201Zavesca Non-Proprietary Name: MiglustatCapsuleOralActelion Pharmaceuticals Us, Inc.ACTIVE
71904-300Opfolda Non-Proprietary Name: MiglustatCapsuleOralAmicus Therapeutics Us, LlcACTIVE